Patient must have valid Social Security number to apply for assistance and receive treatment in the United States.
Patient income must be at or below 500% of the Federal Poverty Level (FPL.)
Patient is required to have insurance coverage which covers at least 50% of the cost of treatment.
Patient must be diagnosed with a covered disease and program must be accepting enrollments.
Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis.
Busulfex
Cyclophosphamide
Cytoxan
Danziten
Gleevec
Iclusig
Imatinib Mesylate
Imkeldi
Roferon-A
Scemblix
Sprycel
Synribo
Tasigna
Chronic myelogenous leukemia (CML) is an uncommon type of cancer of the bone marrow — the spongy tissue inside bones where blood cells are made. CML causes an increased number of white blood cells in the blood. (Source: Mayo Clinic)
Eligibility Criteria
Patient must have valid Social Security number to apply for assistance and receive treatment in the United States.
Patient income must be at or below 500% of the Federal Poverty Level (FPL.)
Patient is required to have insurance coverage which covers at least 50% of the cost of treatment.
Patient must be diagnosed with a covered disease and program must be accepting enrollments.
Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis.
Medications Covered
Busulfex
Cyclophosphamide
Cytoxan
Danziten
Gleevec
Iclusig
Imatinib Mesylate
Imkeldi
Roferon-A
Scemblix
Sprycel
Synribo
Tasigna
Disease Description
Chronic myelogenous leukemia (CML) is an uncommon type of cancer of the bone marrow — the spongy tissue inside bones where blood cells are made. CML causes an increased number of white blood cells in the blood. (Source: Mayo Clinic)
